Article ID Journal Published Year Pages File Type
2082221 Drug Discovery Today: Disease Models 2010 5 Pages PDF
Abstract

Mutations of the bone morphogenetic protein type II receptor (BMPR2) gene were identified in the patients with pulmonary hypertension a decade ago. However, the pathogenesis of the disease remains to be elucidated because of the complex roles of additional genetic and/or environmental factors in the onset of the disease. Genetically modified mice for the BMPR2 gene were reported in the past several years. These findings reveal a crucial role of the BMPR2 gene in the development of pulmonary hypertension.

Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Biotechnology
Authors
,